Table 6 Antimicrobial resistance rate of isolated organisms
From: Clinical impact of body mass index on bactibilia and bacteremia
Organism | Bactibilia (n = 70, 50.4%) | Bacteremia (n = 30, 21.6%) |
|---|---|---|
E. coli | 13/22 (59.1%) ESBL: 6/22 (27.3%) | 2/12 (16.7%) ESBL: 0 |
Klebsiella spp. | 19/19 (100%) ESBL 17/19 (89.5%) | 3/4 (75%) ESBL 2/4 (50%) |
Klebsiella pneumonia | 17/17 (100%) ESBL 9/17 (52.9%) | 3/4 (75%) ESBL 2/4 (50%) |
Klebsiella ozaenae | 1/1 (100%) | |
Klebsiella oxytoca | 1/1 (100%) | |
Enterococcus spp. | 13/14 (92.9%) | 2/2 (100%) |
Enterococcus faecium | 6/6 (100%) | 2/2 (100%) |
Enterococcus casseliflavus | 4/4 (100%) VRE 1/4 (25%) | |
Enterococcus faecalis | 3/3 (100%) | |
Enterococcus durans | 0/1 (0%) | |
Pseudomonas aeruginosa | 10/11 (90.9%) | 4/4 (100%) |
Enterobacter cloacae | 4/4 (100%) | |
Aeromonas spp. | 2/2 (100%) | 1/1 (100%) |
Aeromonas hydrophilia | 1/1 (100%) | |
Aeromonas veronii biovar sobria | 1/1 (100%) | |
Stenotrophomonas maltophilia | 1/2 (50%) | · |
Raoultella planticola | 1/1 (100%) | · |
Acinetobacter baumannii | 1/1 (100%) IRAB 1/1 (100%) | · |
Staphylococcus spp. | · | 6/6 (100%) |
Staphylococcus homonis | 4/4 (100%) | |
Staphylococcus epidermidis | 1/1 (100%) MR-CNS 1/1 (100%) | |
Staphylococcus auricularis | 1/1 (100%) | |
Streptococcus viridans | · | 1/1 (100%) |
Morganella morganii | · | 1/1 (100%) |